400 related articles for article (PubMed ID: 17130296)
21. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; Vande Walle K; Wickes BL; López-Ribot JL
Antimicrob Agents Chemother; 2001 Sep; 45(9):2475-9. PubMed ID: 11502517
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
23. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
[TBL] [Abstract][Full Text] [Related]
24. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
25. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.
Uppuluri P; Srinivasan A; Ramasubramanian A; Lopez-Ribot JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3591-3. PubMed ID: 21518839
[TBL] [Abstract][Full Text] [Related]
26. The synthetic killer peptide KP impairs Candida albicans biofilm in vitro.
Paulone S; Ardizzoni A; Tavanti A; Piccinelli S; Rizzato C; Lupetti A; Colombari B; Pericolini E; Polonelli L; Magliani W; Conti S; Posteraro B; Cermelli C; Blasi E; Peppoloni S
PLoS One; 2017; 12(7):e0181278. PubMed ID: 28704490
[TBL] [Abstract][Full Text] [Related]
27. Synthetic antimicrobial β-peptide in dual-treatment with fluconazole or ketoconazole enhances the in vitro inhibition of planktonic and biofilm Candida albicans.
Mora-Navarro C; Caraballo-León J; Torres-Lugo M; Ortiz-Bermúdez P
J Pept Sci; 2015 Dec; 21(12):853-61. PubMed ID: 26470850
[TBL] [Abstract][Full Text] [Related]
28. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.
do Nascimento Dias J; de Souza Silva C; de Araújo AR; Souza JMT; de Holanda Veloso Júnior PH; Cabral WF; da Glória da Silva M; Eaton P; de Souza de Almeida Leite JR; Nicola AM; Albuquerque P; Silva-Pereira I
Sci Rep; 2020 Jun; 10(1):10327. PubMed ID: 32587287
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
31. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
Singh R; Kumari A; Kaur K; Sethi P; Chakrabarti A
J Med Microbiol; 2018 Jul; 67(7):922-926. PubMed ID: 29767615
[TBL] [Abstract][Full Text] [Related]
32. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
[TBL] [Abstract][Full Text] [Related]
34. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
Xia J; Qian F; Xu W; Zhang Z; Wei X
Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
[TBL] [Abstract][Full Text] [Related]
35. Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions.
Shao J; Cui Y; Zhang M; Wang T; Wu D; Wang C
Pharm Biol; 2017 Dec; 55(1):355-359. PubMed ID: 27931143
[TBL] [Abstract][Full Text] [Related]
36. Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia.
Kraft L; Ribeiro VST; Gonçalves GA; Suss PH; Tuon FF
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Dec; 41(10):596-603. PubMed ID: 36707288
[TBL] [Abstract][Full Text] [Related]
37. Penetration of Candida biofilms by antifungal agents.
Al-Fattani MA; Douglas LJ
Antimicrob Agents Chemother; 2004 Sep; 48(9):3291-7. PubMed ID: 15328087
[TBL] [Abstract][Full Text] [Related]
38. Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.
Maiolo EM; Furustrand Tafin U; Borens O; Trampuz A
Antimicrob Agents Chemother; 2014 May; 58(5):2709-17. PubMed ID: 24566186
[TBL] [Abstract][Full Text] [Related]
39. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
[TBL] [Abstract][Full Text] [Related]
40. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
